Sign in

CIK 0001022079

  • Large accelerated filer

QUEST DIAGNOSTICS INC

Sign in to watch
Ticker
DGX
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
161387862
Phone
+1 973-520-2700
Business address
500 PLAZA DRIVE, SECAUCUS, NJ, 07094
Former names
CORNING CLINICAL LABORATORIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,794,069
in 6 filings, $19.8M under 10b5-1 plans

Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-14 Gregg Vicky B Director Grant or award +1,722 12,125
2019-05-14 MORRISON DENISE M Director Grant or award +1,722 2,212
2019-05-14 RING TIMOTHY M Director Grant or award +1,722 18,576
2019-05-13 DEPPE MICHAEL J VP, Corp. Controller & CAO Grant or award +52 23,671
2019-05-13 DEPPE MICHAEL J VP, Corp. Controller & CAO Grant or award · Non-Qualifed Stock Option (right to buy) +608 608
2019-04-24 Davis J. E. EVP, General Diagnostics Exercise or conversion +47,574 $60.68 $2.9M 84,108
2019-04-24 Davis J. E. EVP, General Diagnostics Sale −47,574 $95.00 $4.5M 36,534
2019-04-24 Davis J. E. EVP, General Diagnostics Exercise or conversion · Stock Options (Right to Buy) −47,574 $60.68 $2.9M 0
2019-04-08 Davis J. E. EVP, General Diagnostics Sale −5,900 $90.15 $532K 38,634
2019-04-08 Davis J. E. EVP, General Diagnostics Sale −2,100 $90.70 $190K 36,534
2019-04-04 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Exercise or conversion +60,492 $71.17 $4.3M 133,908
2019-04-04 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Sale −60,492 $90.59 $5.5M 73,416
2019-04-04 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Sale −5,890 $90.59 $534K 67,526
2019-04-04 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Exercise or conversion · Non-Qualifed Stock Option (right to buy) −60,492 $71.17 $4.3M 0
2019-04-01 RING TIMOTHY M Director Grant or award · Phantom Stock Units +340 $90.60 $31K 7,971.68
2019-04-01 MORRISON DENISE M Director Grant or award · Phantom Stock Units +311 $90.60 $28K 474
2019-03-04 PREVOZNIK MICHAEL E SVP & General Counsel Sale −3,373 $86.81 $293K 39,458
2019-03-04 Cunningham Everett SVP, Commercial Sale −3,892 $86.81 $338K 38,311
2019-03-01 RUSCKOWSKI STEPHEN H Chairman, President and CEO Grant or award +38,341 $86.86 $3.3M 235,747
2019-03-01 RUSCKOWSKI STEPHEN H Chairman, President and CEO Shares withheld for taxes −22,698 $86.86 $2.0M 213,049

Page 48 of 52 · 1,040 trades